Stay updated on Lintuzumab-Ac225 in Older AML Patients Clinical Trial

Sign up to get notified when there's something new on the Lintuzumab-Ac225 in Older AML Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lintuzumab-Ac225 in Older AML Patients Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.7%
    Check dated 2025-05-01T05:54:04.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2025-04-23T22:38:04.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The web page has undergone significant content removal, particularly regarding a detailed Phase I/II study of Lintuzumab-Ac225 for treating untreated acute myeloid leukemia, including study design, inclusion and exclusion criteria, and patient management details. Additionally, the version number has been updated from v2.14.4 to v2.15.0.
    Difference
    29%
    Check dated 2025-04-16T14:48:34.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.3%
    Check dated 2025-04-09T10:22:41.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T23:42:00.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-03-25T14:20:35.000Z thumbnail image

Stay in the know with updates to Lintuzumab-Ac225 in Older AML Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lintuzumab-Ac225 in Older AML Patients Clinical Trial page.